$SCTX
Scribe Therapeutics Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$33.00
▲+2.68%+$0.860
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateScribe Therapeutics Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is SCTX up today? It is at $33.00 (+2.68%), and our scanner flagged it 46 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SCTX spikes, and full due diligence on SCTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SCTX 46 times in the last 30 days. Create a free account to track $SCTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SCTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SCTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing10-QQuarterly report (10-Q)Sep 2, 2026 · 18 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Aghazadeh Behzad Director | Bought (open market) | +8K 0.04% of company | added 0.3% | 3.09M | $144K at $18.25 | Jul 28, 26 |
Doudna Jennifer A Beneficial Owner (10%) | Acquired (grant/award) | +13K 0.07% of company | added 2.1% | 604K | n/a | Jul 27, 26 |
Orbimed Advisors Llc Director | Acquired (grant/award) | +349K 1.8% of company | n/a | 349K | n/a | Jul 27, 26 |
Orbimed Advisors Llc Director | Bought (open market) | +1.00M 5.3% of company | added 100% | 1.35M | $15.0M at $15.00 | Jul 27, 26 |
Gordon Carl L Director | Acquired (grant/award) | +349K 1.8% of company | n/a | 349K | n/a | Jul 27, 26 |
Gordon Carl L Director | Bought (open market) | +1.00M 5.3% of company | added 100% | 1.35M | $15.0M at $15.00 | Jul 27, 26 |
Ah Bio Fund Ii, L.P. Beneficial Owner (10%) | Acquired (grant/award) | +2.75M 14.5% of company | n/a | 2.05M | n/a | Jul 27, 26 |
Ah Bio Fund Ii, L.P. Beneficial Owner (10%) | Bought (open market) | +333K 1.8% of company | added 12% | 3.08M | $5.0M at $15.00 | Jul 27, 26 |
Aghazadeh Behzad Director | Bought (open market) | +2.38M 12.6% of company | added 100% | 3.08M | $35.7M at $15.00 | Jul 24, 26 |
Parrot David Officer | Bought (open market) | +3K 0.01% of company | n/a | 3K | $40K at $15.00 | Jul 23, 26 |
Lucas Svetlana Officer | Bought (open market) | +3K 0.02% of company | n/a | 3K | $45K at $15.00 | Jul 23, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on SCTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SCTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SCTX last traded at $33.00, up 2.68% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The SCTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SCTX 46 times in the last 30 days.
SCTX (Scribe Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $625M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SCTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SCTX discussion
Sign in to ask a question or join the discussion.